Akari Therapeutics (AKTX) Treasury Shares (2022 - 2025)

Akari Therapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $1465.0 for Q4 2025.

• In Q4 2025, Treasury Shares changed N/A year-over-year to $1465.0; the TTM figure through Dec 2025 stood at $1465.0 (changed N/A YoY), while the FY2025 annual figure was $1465.0, changed N/A from the prior year.
• Treasury Shares came in at $1465.0 for Q4 2025 at Akari Therapeutics, down from $251.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $386.0 million in Q4 2023 to a low of $1465.0 in Q4 2025.
• A 4-year average of $199.9 million and a median of $251.8 million in 2024 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 1697.2% in 2023 and fell as far as 1697.2% in 2023.
• Akari Therapeutics' Treasury Shares stood at $21.5 million in 2022, then soared by 1697.2% to $386.0 million in 2023, then tumbled by 34.75% to $251.8 million in 2024, then sank by 100.0% to $1465.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $1465.0, $251.8 million, and $251.8 million for Q4 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison